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Cocaine is a commonly used illicit drug among HIV-1 infected individuals and is known
to increase HIV-1 replication in permissive cells including PBMCs, CD4+ T cells, and
macrophages. Cocaine’s potentiating effects on HIV-1 replication in macrophages-
the primary targets of the virus in the central nervous system, has been suggested
to play an important role in HIV-1 neuro-pathogenesis. However, the mechanism by
which cocaine enhances HIV-1 replication in macrophages remain poorly understood.
Here, we report the identification of cocaine-induced signaling events that lead to
enhanced HIV-1 transcription in macrophages. Treatment of physiologically relevant
concentrations of cocaine enhanced HIV-1 transcription in a dose-dependent manner in
infected THP-1 monocyte-derived macrophages (THP-1macs) and primary monocyte-
derived macrophages (MDMs). Toward decoding the underlying mechanism, results
presented in this report demonstrate that cocaine induces the phosphorylation of p38
mitogen activated protein kinase (p38 MAPK), a known activator of HIV-1 transcription.
We also present data suggesting that the p38 MAPK-driven HIV-1 transcription is
dependent on the induction of mitogen- and stress-activated protein kinase 1 (MSK1).
Consequently, MSK1 mediates the phosphorylation of serine 10 residue of histone 3
(H3 Ser10), which is known to activate transcription of genes including that of HIV-
1 in macrophages. Importantly, our results show that inhibition of p38 MAPK/MSK1
signaling by specific pharmacological inhibitors abrogated the positive effect of cocaine
on HIV-1 transcription. These results validate the functional link between cocaine and
p38 MAPK/MSK1 pathways. Together, our results demonstrate for the first time that
the p38 MAPK/MSK1 signaling pathway plays a critical role in the cocaine-induced
potentiating effects on HIV-1 infection, thus providing new insights into the interplay
between cocaine abuse and HIV-1 neuro-pathogenesis.
Keywords: cocaine, HIV, p38 MAPK, MSK1, macrophages
INTRODUCTION
The Central Nervous System (CNS) is a major target of Human Immunodeficiency Virus
type 1 (HIV-1; McArthur et al., 2010). HIV-1 enters the CNS early in infection and leads to
progressive neuronal dysfunction and degeneration (Kaul et al., 2001; Nath, 2002; Rao et al., 2014)
that collectively constitute HIV-associated neurological disorders (HAND; Woods et al., 2009;
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Patel et al., 2013; Sanmarti et al., 2014). HAND affects 20–
30% patients in the late stages of AIDS and is believed to
be the most common cause of dementia worldwide among
people aged 40 and below (Vivithanaporn et al., 2010). While
antiretroviral therapy (ART) has dramatically reduced HIV-
1 associated dementia (Joska et al., 2010), the milder forms
of HAND continues to be a major health concern for HIV-
1 patients (Joska et al., 2010). Cocaine, a commonly abused
drug among HIV-1 positive individuals, has been associated
with worsening of HAND pathogenesis (Pakesch et al., 1992;
Larrat and Zierler, 1993; Goodwin et al., 1996; Nath et al.,
2001; Ferris et al., 2008; Norman et al., 2009). Several
mechanisms have been proposed for the potentiating effects of
cocaine on HAND including enhanced neuro-invasion of HIV-
1, increased viral replication in the CNS, and elevated toxic
effects of HIV-1 viral proteins (Pakesch et al., 1992; Larrat
and Zierler, 1993; Goodwin et al., 1996; Nath et al., 2001;
Ferris et al., 2008; Norman et al., 2009). Though neurons are
generally refractory to HIV-1 (van de Bovenkamp et al., 2002),
resident macrophages/microglia support HIV-1 infection and
serve as a reservoir for the virus in the CNS (Koppensteiner
et al., 2012). Ongoing viral replication in these cells are
hypothesized to drive HIV-1 neuro-pathogenesis by releasing
viral and cellular factors that induce neuroinflammation and
neurotoxicity (Gonzalez-Scarano and Martin-Garcia, 2005; Rao
et al., 2014). However, the exact mechanism(s) by which
cocaine potentiates HIV-1 replication in macrophages is poorly
understood.
Cocaine enhances HIV-1 replication in various permissive
cell types including peripheral blood mononuclear cells (PBMCs;
Peterson et al., 1991, 1992; Bagasra and Pomerantz, 1993), CD4+
T cells (Mantri et al., 2012; Kim et al., 2013; Addai et al.,
2015), dendritic cells (Napuri et al., 2013), and macrophages
(Dhillon et al., 2007). These studies suggest that to increase
HIV-1 replication cocaine targets both entry and post-entry
steps of infection. It has been reported that, cocaine promotes
the entry of HIV-1 into target cells by inhibiting anti-viral
chemokines and upregulating the co-receptors (CXCR4 and/or
CCR5) that mediate viral entry and fusion (Nair et al., 2000,
2001; Roth et al., 2005; Reynolds et al., 2009). Studies also
support that cocaine alters HIV-1 post entry steps including
reverse transcription, integration, and viral mRNA transcription.
Recently, we have demonstrated that in CD4+ T cells cocaine
downregulates “miR-125b” (Mantri et al., 2012), an anti-HIV
cellular miRNA that inhibits HIV-1 protein translation by
binding to viral transcripts (Huang et al., 2007). Cocaine
also downregulates another cellular miRNA called miR-155
(Napuri et al., 2013), which negatively regulates DC-SIGN
that plays a critical role in HIV-1 infection of dendritic cells
(Napuri et al., 2013). Cocaine has also been shown to enhance
HIV-1 reverse transcription in quiescent CD4+ T cells (Kim
et al., 2013). Along these lines, very recently, we reported
that cocaine treatment increases HIV-1 proviral integration in
CD4+ T cells (Addai et al., 2015). Further, proteomic analysis
of cocaine-treated astrocytes revealed differential regulation of
several host proteins that may potentially influence HIV-1
replication (Reynolds et al., 2006). Collectively, these studies
highlight the potential mechanisms by which cocaine might
modulate both entry and post entry steps of HIV-1 replication
in PBMCs, CD4+ T cells, astrocytes, and dendritic cells.
However, the cellular pathways and the steps of replication
that are targeted by cocaine in macrophages remain poorly
understood.
The goal of this study was to decipher the mechanism by
which cocaine increases HIV-1 replication in macrophages.
HIV-1 replication can be modulated by cellular signaling
pathways known to stimulate HIV-1 LTR driven transcription
(Herbein et al., 2010). In macrophages, activation of
nuclear factor kappa B (NF-κB), mitogen activated protein
kinases (MAPK), and Janus kinase/signal transducer and
activator of transcription (JAK/STAT) have been reported
to stimulate HIV-1 transcription (Herbein et al., 2010).
Cocaine has also been reported to alter cellular gene
expression by targeting MAPK, PI3K/Akt pathway, and
mitogen- and stress-activated protein kinases 1 (MSK1; Yao
et al., 2009; Yang et al., 2010; Mannangatti et al., 2015). In
the present study, we demonstrate that cocaine enhances
HIV-1 transcription in macrophages by targeting the p38
MAPK/MSK1 pathway. Using THP-1macs and primary
MDMs, we show that cocaine induces the phosphorylation
of p38 MAPK, which then activates the MSK1 pathway
that subsequently promotes the phosphorylation of serine
10 residue of histone 3 (H3 Ser10). We also demonstrate
that inhibition of p38 MAPK/MSK1 pathway abrogates
cocaine’s positive effects on HIV-1 transcription. Together,
our results strongly implicate the p38 MAPK/MSK1 signaling
in cocaine-treated macrophages and provide mechanistic
insights into the potentiating effects of this illicit drug on HIV-1
replication.
MATERIALS AND METHODS
Reagents and Antibodies
Cocaine Hydrochloride was purchased from Sigma Chemicals
(St. Louis, MO, USA). P38 MAPK inhibitor-SB203580, Anti-p38
and anti-phospho-p38 antibodies were purchased from Cell
Signaling Technology (Danvers, MA, USA). The MSK1 inhibitor
SB747651A was purchased from R&D Systems (Minneapolis,
MN, USA). Anti-phospho p38-Alexa 647 conjugate was
purchased from Beckman Coulter (Brea, CA, USA). Anti-MSK1,
anti Phospho-MSK1, anti-Histone H3, and anti-phospho-Ser 10
Histone H3 were obtained from Millipore (Billerica, MA, USA)
and anti-actin antibody was obtained from Sigma (St. Louis,
MO, USA). The plasmids pLVSV-G and pNL4-3.Luc.R−E−
were gifts from Dr. Vineet KewalRamani (NCI/NIH). The
following reagent were obtained through the NIH AIDS
Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH: TZM-bl from Dr. John C. Kappes, Dr. Xiaoyun
Wu and Tranzyme Inc. The monocytic THP-1 cell line was
obtained from American Type Culture Collection (ATCC).
Whole human blood was purchased from the New York Blood
Center in accordance with Meharry Medical College IRB
guidelines.
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Cell Culture, Isolation of PBMCs,
Purification of Primary Monocytes, and
Generation of Monocyte-Derived
Macrophages (MDMs)
THP-1 cell line was maintained in complete RPMI (cRPMI)
media containing RPMI supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 2 mM L-glutamine,
and antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin).
THP-1 monocytes were differentiated into macrophages (THP-
1macs) by culturing them with 10 ng/mL of phorbol 12-myristate
13-acetate (PMA) for 72 h.
For primary cell isolation, fresh human blood was diluted
1:2 with phosphate buffered saline (PBS), overlaid on 12.5 ml
of Ficoll-PaqueTM Premium reagent (GE) in a 50 ml conical
tube, and centrifuged at 750 × g for 20 min at 20◦C. The
interphase layer of human PBMCs was carefully transferred to a
new 50 ml conical tube and PBS was added to make up to 50 ml.
Subsequently, the PBMCs were washed several times with PBS
by centrifugation to remove unwanted cell types. The resulting
cell pellet was resuspended in PBS, and the cell number and
viability were determined by trypan blue exclusion. Monocytes
were then isolated from the PBMCs by negative selection using
the Monocyte Isolation kit II (Miltenyi Biotec) and following the
manufacturer-recommended protocol. The isolated monocytes
were cultured in RPMI 1640 supplemented with 20% heat-
inactivated FBS, 2 mM L-glutamine, and antibiotics. These
monocytes were then differentiated to macrophages (MDMs) by
culturing them in 10 ng/ml M-CSF (10 ng/ml; Life Technologies,
Carlsbad, CA, USA) for 5–7 days.
Virus Production and Infection
VSV-G-pseudotyped HIV-1 encoding the firefly luciferase was
generated by co-transfecting the HIV-1 molecular clone pNL4-
3.Luc.R−E− and pLVSV-G into 293T cells by using Polyfect
(Qiagen) as per the manufacturer-recommended protocol. After
48–72 h, culture supernatant containing the virus particles
was collected, centrifuged at low-speed and filtered through a
0.45 µM-pore-size membrane. Infectivity of the virions was
measured by luciferase reporter assay using TZM-bl cells that
harbor a firefly luciferase reporter gene under the control of
HIV-1 promoter. THP-1macs and MDMs (5 × 104 cells) were
infected with VSV-G-pseudotyped HIV-1 by spinoculation. Six
hours post-infection, cells were washed with PBS, treated with
varying concentrations of cocaine, and incubated at 37◦C. After
48–72 h, cells were washed, lysed, and luciferase activity was
measured using a luminescence microplate reader (BioTek).
HIV-1 BAL virions were obtained from the NIH AIDS Reagent
Program, Division of AIDS, NIAID, NIH. THP-1macs were
infected with HIV-1 BAL virions (MOI ∼ 1.0) by spinoculation
in the presence of polybrene (Sigma) and were cultured (4 × 105
cells/ml) for 3 days in the presence or absence of cocaine.
Productive infection was measured by detecting intracellular
HIV-1 p24 protein using western blot. Activation of p38
MAPK/MSK1 pathway in infected cells was measured by western
blot using cellular lysates of infected cells treated with or without
cocaine.
Western Blotting
Cell lysates were prepared using standard protocols and the
total protein concentrations were determined by BCA protein
assay. Equal amounts of total protein from the cell lysates were
resolved by SDS-PAGE and then transferred to nitrocellulose
membranes by using a semi-dry blotter (Bio-Rad, Hercules,
CA, USA). The membranes were incubated in 5% (w/v) non-
fat milk in TBST (10 mM Tris. pH 8.0, 150 mM NaCl,
and 0.1% Tween 20). Membranes were then probed with
primary antibodies recognizing antigens of interest, followed
by incubation with appropriate secondary antibodies (1:2000
dilution) conjugated to horseradish peroxidase. Immunoblots
were washed in TBST (pH 8.0; Sigma) and developed using
the enhanced chemiluminescence system (Pierce ECL, Thermo
Scientific).
Flow Cytometry Analysis
For intracellular staining of phosphorylated p38-MAPK and
MSK1, THP-1macs and MDMs were harvested by scraping
with 10% (w/v) StemPro Accutase cell detachment solution
(Life Technologies, Carlsbad, CA, USA) and collected by
centrifugation. The cells were then washed with PBS and fixed
in 4% (w/v) paraformaldehyde at 4◦C for 15 min. Cells were
then incubated on ice for 1 min and washed with PBS. Following
fixation, cells were permeabilized in 90% (w/v) methanol for
30 min on ice. Cells were washed and re-suspended in PBS
containing 0.5% BSA. Upon washing, the cells were stained
for phospho-p38 and phospho-MSK1 using Alexa Fluor 647
rabbit anti-phospho-p38 and anti-phospho-MSK1 antibodies
(BD Biosciences) according to the manufacturer’s instructions.
Flow cytometry was performed after a final wash (PBS containing
0.5% BSA) using a BD FACSCaliburTM flow cytometer (BD
Biosciences) and data were collected and analyzed using Flow Jo
(Tristar) software.
Cytotoxicity Assay
Cells were treated with cocaine for 24 h and cytotoxicity
was measured by using Vybrant MTT Cell Proliferation Assay
Kit as per the manufacturers’ instructions (Thermo Fisher,
USA).
Statistical Analysis
Data are analyzed by one-way analysis of variance (ANOVA)
and presented as mean ± SD of three independent experiments.
Significance of differences between control and cocaine-
treated samples was determined by Turkey post hoc test.
Values of p < 0.05 were considered to be statistically
significant.
RESULTS
Cocaine Enhances HIV-1 Transcription in
Macrophages
Cocaine is known to enhance HIV-1 replication in permissive cell
types including macrophages. Macrophages express the CCR5
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co-receptor (Grivel et al., 2011) and cocaine has been shown to
upregulate CCR5 expression (Nair et al., 2000). Because HIV-
1 entry into macrophages is mediated by the cellular receptor
CD4 and the co-receptors-CCR5 (Grivel et al., 2011), it has
been suggested that cocaine’s potentiating effect on HIV-1 in
macrophages may depend on increased viral entry. We have
previously demonstrated that cocaine targets post-entry steps
of HIV-1, which causes increased viral replication in CD4+
T cells [30, 31, 32]. To test whether cocaine modulates post
entry steps of HIV-1 infection in macrophages, we performed
single-cycle replication assays using a luciferase encoding HIV-
1 reporter virus. The THP-1macs were infected with HIV-1
virions by spinoculation and then cultured in the presence
of cocaine at concentrations ranging from 0.1 to 100 µM.
These concentrations cover the wide range of plasma levels
of cocaine reported in drug users (Van Dyke et al., 1976;
Mittleman and Wetli, 1984; Peretti et al., 1990; Karch et al.,
1998; Blaho et al., 2000; Heard et al., 2008). The viral replication
levels were evaluated by lysing the cells 48–72 h post infection
(hpi) and measuring luciferase activity in the cell lysates.
As shown in Figure 1A, cocaine treatment increased HIV-1
promoter driven luciferase activity in THP-1macs compared to
untreated infected cells. Importantly, increasing concentrations
of cocaine caused a dose-dependent increase in luciferase
activity (Figure 1A), with 25 µM cocaine producing the
maximum activity corresponding to ∼threefold increase in
viral replication compared to untreated cells (Figure 1B).
Cytotoxicity measurements revealed that treatment of cocaine
at concentrations of 1 µM through 100 µM exhibited minimal
toxicity to THP-1macs (Figure 1C).
FIGURE 1 | Cocaine increases HIV-1 transcription in THP-1macs. THP-1macs were inoculated with pseudotyped HIV-1 encoding an LTR-driven luciferase
reporter and then were cultured in the absence or presence of cocaine at concentrations ranging from 0.1 to 100 µM to cover the wide range of plasma
concentrations reported in cocaine users. (A) Viral replication was monitored 48–72 hpi by measuring luciferase activity in the cell lysates. (B) Fold change in viral
replication was determined by comparing the luciferase activity of cocaine-treated cells to that of the untreated cells. (C) THP-1macs were cultured in the absence or
presence of cocaine at concentrations ranging from 0.1 to 100 µM. Cytotoxicity was measured by optical density at 570 nm using MTT based assay. The results are
expressed as mean ± SE for three independent experiments. ∗p < 0.05 is for the comparison of cocaine treated cells vs. untreated cells.
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Cocaine Activates p38 MAPK in
Macrophages
As cocaine treatment potentiated the HIV-1 LTR promoter-
driven transcription, we sought to understand the underlying
mechanistic details. We focused on the p38 MAPK pathway
based on two lines of published data showing that: (1) cocaine
activates p38 MAPK in neurons and astrocytes (Yao et al., 2009;
Yang et al., 2010), and (2) p38 MAPK activates HIV-1 LTR-
driven transcription in monocytic cell lines and macrophages
(Muthumani et al., 2004; Horie et al., 2007; Kadoki et al., 2010;
Sahu et al., 2015). To test this, first we investigated whether
cocaine activates p38 MAPK in macrophages. We treated THP-
1macs with 1, 5, and 25 µM cocaine, concentrations that
stimulated HIV-1 transcription in these cells (Figure 1). After
cocaine treatment, cells were lysed and expression levels of total
p38 and phosphorylated p38 (phospho-p38) were examined by
immunoblot. Data from these experiments show that cocaine
treatment significantly enhanced phospho-p38 levels relative to
the untreated cells (Figure 2A). Densitometry analysis revealed
a ∼sixfold to sevenfold increase in phospho-p38 levels in cells
treated with 5 and 25 µM cocaine compared to untreated cells
(Figure 2B). Determination of the ratio between the phospho-
p38 level to the total p38 MAPK level for respective cocaine
concentrations revealed a ∼eightfold to 10-fold increase in
phosphorylation of p38 MAPK in cells treated with 5 and 25 µM
cocaine (Figure 2C). Importantly, the maximum increase in
phospho-p38 levels at 25 µM cocaine correlated with the greatest
increase in HIV-1 transcription induced by 25 µM cocaine
(Figure 1). These data strongly indicate that cocaine targets and
activates the p38 MAPK in macrophages.
Cocaine-Mediated Phosphorylation of
p38 MAPK Leads to the Activation of
MSK1
Having determined that cocaine induces phosphorylation of p38
MAPK (Figure 2A), we then sought to identify the downstream
FIGURE 2 | Cocaine induces p38 MAPK/MSK1/H3-Ser10 signaling cascade in uninfected THP-1macs. THP-1macs were cultured in the presence of
increasing concentrations of cocaine overnight. Cells were harvested and levels of p38 MAPK, MSK1, and H3 Ser10 were assessed. (A) Levels of total p38 and
phospho-p38 by western blot analysis. Densitometry analysis of fold change in phospho-p38 levels in cocaine-treated cells relative to untreated cells (B), and fold
change in phospho-p38 levels relative to total p38 for respective cocaine concentrations (C). (D) Levels of total MSK1 and phospho-MSK1 by western blot analysis.
Densitometry analysis of fold change in phospho-MSK1 levels in cocaine-treated cells relative to untreated cells (E), and fold change in phospho-MSK1 levels relative
to total MSK1 for respective cocaine concentrations (F). (G) Levels of total H3 and phospho-H3 Ser10 by western blot analysis. Densitometry analysis of fold
change in phospho-H3 Ser10 levels in cocaine-treated cells relative to the untreated cells (H), and fold change in phospho-H3 Ser10 levels relative to total H3 for
respective cocaine concentrations (I). The results are expressed as mean ± SE for three independent experiments. ∗p < 0.05 is for the comparison of cocaine
treated cells vs. untreated cells.
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effectors of p38-MAPK in cocaine-treated macrophages. We
chose to evaluate the MSK1, because it is a known target of
p38 MAPK (Vermeulen et al., 2009) and is also activated by
cocaine (Brami-Cherrier et al., 2005). To test this, THP-1macs
were treated with 1, 5, and 25 µM cocaine and the lysates of
these cells were analyzed for the activation of MSK1 by measuring
phosphorylation of MSK1 by western blot. As shown in
Figure 2D, cells exposed to cocaine exhibited increased phospho-
MSK1 levels compared to the untreated cells. Densitometry
analysis showed that the increase in MSK1 phosphorylation was
optimal (∼twofold to threefold) in cells treated with 5 µM
cocaine (Figure 2E). The p38 MAPK activity, expressed as the
ratio of phosphorylated to total p38 MAPK levels, rose to the
maximum (∼ twofold) in cells treated with 5 or 25 µM cocaine
(Figure 2F). These results indicate that the p38 MAPK/MSK1
pathway may be an important determinant of cocaine-mediated
signaling in THP-1macs.
Cocaine-Induced Activation of p38
MAPK/MSK1 Pathway Stimulates
Phosphorylation of Histone H3 at Ser10
Mitogen- and stress-activated protein kinases 1 is a key signaling
molecule downstream of p38 MAPK and is known to induce
phosphorylation of the serine 10 of histone H3 (H3 Ser10;
McCoy et al., 2005, 2007). Studies have demonstrated that MSK1
is required for stress-induced phosphorylation of H3 Ser10
resulting in transcriptional activation of cellular genes (Keum
et al., 2013). Interestingly, MSK1/H3 Ser10 has also been reported
to drive viral transcription (Sahu et al., 2015). Therefore, we
hypothesized that cocaine-mediated activation of MSK1 signaling
could lead to phosphorylation and activation of H3 Ser10. To
test this, we measured the phosphorylation of H3 Ser10 in
cocaine-treated cell lysates of THP-1macs by western blot. Data
in Figure 2G showed that cocaine treatment (18–24 h) increased
the H3 phospho-Ser10 levels in a dose dependent manner. In
densitometry analysis, cells treated with 25 µM cocaine exhibited
the highest levels of H3 phospho-Ser10 when compared to the
untreated cells (Figure 2H). The ratio of H3 phospho-Ser10 to
the total H3 Ser10 also indicated that 25 µM cocaine caused
the greatest (threefold) increase in phosphorylation (Figure 2I).
Taken together, these data suggest that the p38 MAPK/MSK1
pathway promotes phosphorylation and activation of H3 Ser10
in cocaine- treated THP-1macs.
Inhibiting p38 MAPK/MSK1 Pathway
Abrogates Cocaine-Mediated Effects on
HIV-1 Transcription
We probed the specificity of the induction of p38 MAPK/MSK1
pathway in cocaine treated THP1macs by using the
pharmacological inhibitors specific for p38 MAPK (SB-203580;
Davies et al., 2000) and MSK1 (SB-747651A; Naqvi et al., 2012).
THP1macs were pretreated with either DMSO, or p38 MAPK
inhibitor (10 µM) or MSK1 inhibitor (10 µM) prior to cocaine
(25 µM) treatment (Figure 3B). Then, flow cytometry was used
FIGURE 3 | Induction of p38 MAPK/MSK1 signaling cascade in uninfected THP-1macs by cocaine can be abrogated by pharmacological inhibitors of
p38 MAPK and MSK1. THP-1macs were pretreated with 10 µM p38 MAPK inhibitor (SB-203580) or 10 µM MSK1 inhibitor (SB-747651A) for 1 h prior to overnight
treatment with cocaine. Cells were then harvested, stained with appropriate antibodies or isotype controls, and analyzed by flow cytometry. (A) Levels of
phospho-MSK1 in cocaine-treated cells. Levels of phospho-MSK1 in cocaine- and p38 MAPK inhibitor-treated cells (B), and in cocaine- and MSK1 inhibitor-treated
cells (C).
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to analyze the phosphorylation levels of MSK1 and thus its
activation status. As hypothesized, in the absence of p38 MAPK
inhibitor, cocaine increased the phosphorylation levels of MSK1
in THP1macs (Figure 3A). In contrast, in THP-1macs pretreated
with the p38 MAPK inhibitor, cocaine had only a minimal effect
on the phosphorylation status of MSK1 (Figure 3B). Likewise,
cocaine failed to induce MSK1 phosphorylation in cells treated
with MSK1 inhibitor (Figure 3C). However, in the absence of
the MSK1 inhibitor, cocaine induced MSK1 phosphorylation
(Figure 3C). The results of these experiments provide further
evidence that cocaine specifically targets the p38 MAPK/MSK1
pathway in THP-1macs.
Cocaine-Induced Activation of p38
MAPK/MSK1 Signaling Leads to
Enhanced Transcription of HIV-1 in
Macrophages
We then investigated whether cocaine activates the p38
MAPK/MSK1 pathway in HIV-1-infected THP-1macs. Cells were
inoculated with VSV-G-pseudotyped HIV-1-Luc reporter virions
and then cultured in the presence or absence of cocaine (25 µM).
Productive HIV-1 infection in THP-1macs was confirmed by
measuring luciferase activity in the cell lysates (data not shown).
Data from western blot analysis showed that cocaine stimulated
the phosphorylation of p38 MAPK (Figures 4A,B) and MSK1
(Figures 4C,D) in HIV-1-infected THP1macs.
FIGURE 4 | Cocaine induces p38 MAPK/MSK1 signaling in
HIV-1-infected THP-1macs. (A) THP-1macs were inoculated with
pseudotyped HIV-1 and then cultured in the absence or presence of 25 µM
cocaine. Cells were harvested 48 hpi and cell lysates were analyzed by
western blot. (A) Levels of total p38 MAPK and phospho-p38 MAPK. (B) Fold
change in phospho-p38 MAPK levels in cocaine-treated cells relative to
untreated cells. (C) Levels of total MSK1 and phospho-MSK1 levels. (D) Fold
change in phospho-MSK1 levels in cocaine-treated cells relative to untreated
cells. The results in (B,D) are expressed as mean ± SE for three independent
experiments. ∗p < 0.05 is for the comparison of cocaine treated cells vs.
untreated cells.
Next, we tested whether activation of the p38 MAPK and
MSK1 pathways is essential for the cocaine-induced stimulation
of HIV-1 transcription in THP-1macs (Figures 1A,B). To
test this possibility, THP-1macs were inoculated with VSV-
G-pseudotyped HIV-1-Luc reporter virions. Then these cells
were pretreated with p38 MAPK inhibitor or DMSO for 1 h,
and then cultured in the presence or absence of cocaine
(25 µM). Recapitulating the data shown in Figure 1, HIV-
1 transcription, as evidenced from the luciferase activity, was
significantly elevated in THP-1macs pretreated with DMSO and
cultured in the presence of cocaine, compared to control cells
(Figures 5A,B). In contrast, a significant decrease in luciferase
activity was observed in THP-1macs pretreated with p38 MAPK
inhibitor and cultured in the presence of cocaine. These results
confirm the functional role of the p38 MAPK/MSK1 pathway
in the cocaine-induced enhancement of HIV-1 transcription in
THP-1macs.
Result in Figures 4 and 5 support the hypothesis that
cocaine enhances HIV-1 transcription in macrophages by
activating the p38 MAPK/MSK1 signaling cascade. However,
in these studies used pseudotyped HIV-1 virions that bypass
the CD4 and CXCR4/CCR5 receptor mediated entry of
infectious virions. Therefore, to test the physiological relevance
of the link between activation of p38/MSK1 pathway and
viral transcription, we carried out infection experiments using
infectious HIV-1 virions. We infected THP-1macs with the
R5 tropic HIV-1 BAL virions and confirmed productive
infection by measuring HIV-1 p24 protein in the cellular
lysates by immunoblotting. Results in Figures 6A,B showed
that cocaine (25 µM) treatment increased the levels of p24
protein relative to untreated cells. These results support the
potentiating effects of cocaine on viral transcription that was
observed with pseudotyped HIV-1 virions (Figure 5). Then,
FIGURE 5 | Cocaine-induced p38 MAPK signaling enhances HIV-1
transcription in THP-1macs. THP-1macs were inoculated with
pseudotyped HIV-1 and then were cultured in the absence or presence of
25 µM cocaine with or without pretreatment with 10 µM p38 MAPK inhibitor
(SB-203580). (A) Viral replication was monitored 48–72 hpi by measuring
luciferase activity in the cell lysates. (B) Fold change in viral replication was
determined by comparing the luciferase activity of cocaine-treated cells to that
of the untreated cells. The results are expressed as mean ± SE for three
independent experiments. ∗p < 0.05 is for the comparison of cocaine treated
cells vs. untreated cells. ∗∗p < 0.05 is for the comparison of cocaine treated
cells vs. cocaine and inhibitor treated cells.
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FIGURE 6 | Cocaine activates p38 MAPK/MSK1/H3Ser10 signaling in THP-1macs infected with R5 tropic HIV-1 BAL virions. THP-1macs were
inoculated with HIV-1 BAL virions and spinoculated for 2 h. These cells were then cultured with or without cocaine (25 µM). (A) Viral replication was monitored 72 hpi
by measuring HIV-1 p24 protein in the cell lysates by immunoblot. (B) Fold change in p24 levels in cocaine-treated cells relative to untreated cells. (C) Levels of total
p38 MAPK and phospho-p38 MAPK, total MSK1 and phosphor-MSK1, and total H3 Ser10, and phosphor-H3 Ser10 were measured in the lysates by immunoblot.
(D) Fold change in respective phosphorylated protein levels in cocaine-treated cells relative to untreated cells. The results are expressed as mean ± SE for three
independent experiments. ∗p < 0.05 is for the comparison of cocaine treated cells vs. untreated cells.
we measured the activation of p38 MAPK/MSK1/H3 ser10
signaling cascade in the cellular lysates of THP1macs infected
with HIV-1 BAL virions (Figures 6C,D). These data revealed
that cocaine treatment induced phosphorylation of p38 MAPK,
MSK1, and H3 Ser10 and provide further evidence that cocaine
treatment activates p38 MAPK/MSK1/H3 ser10 signaling cascade
in macrophages.
Cocaine-Induced Activations of
p38-MAPK/MSK1 Pathway Leads to
Enhanced HIV-1 Transcription in Primary
MDMs
Differentiated THP-1 monocytic cells (THP-1macs) used in this
study is an excellent model system and has been extensively
used to study signaling pathways of macrophages (Nong
et al., 1991; Gomez-Marin et al., 1998; Dreskin et al., 2001;
Vuletic et al., 2011). This is mainly because the differentiated
THP1macs adhere, stop proliferating, demonstrate increased
phagocytosis, and other macrophage physiology (Nong et al.,
1991; Gomez-Marin et al., 1998; Dreskin et al., 2001; Vuletic
et al., 2011). These attributes of THP-1macs have also been
useful in understanding HIV-1 biology in macrophages (Nong
et al., 1991). However, being a human monocytic leukemia cell
line, results using THP-1macs may not exactly recapitulate the
signaling cascades of primary macrophages. Therefore, we tested
the effects of cocaine on p38 MAPK, MSK1, and H3 Ser10
in primary monocyte-derived macrophages (MDMs). Primary
monocytes were isolated from PBMCs of three healthy donors
and were differentiated into macrophages by treatment with
M-CSF (10 ng/mL) for 5–7 days. These MDMs were inoculated
with VSV-G-pseudotyped HIV-1-Luc reporter virus and then
cultured in the absence or presence of cocaine (1–100 µM).
HIV-1 LTR promoter drive transcription in the MDMs were
determined by assaying the luciferase activity in the cell lysates
48–72 hpi. Results from these assays reveal that cocaine treatment
increased the HIV-1 LTR-driven transcriptional activity in the
MDMs in a dose dependent manner, with 25 µM concentration
inducing the highest enhancement (Figure 7). These results
are comparable to the HIV-1 transcription levels determined in
cocaine-treated THP-1macs (Figure 1). Collectively, these data
further emphasize that cocaine enhances HIV-1 transcription in
macrophages.
We then sought to determine whether the cocaine-induced
enhancement in HIV-1 transcription in MDMs is mediated
via the activation of the p38 MAPK/MSK1 signaling cascade
in primary macrophages as has been the case in the THP-
1macs. To test this, we treated MDMs with cocaine and
measured phosphorylation of p38 MAPK and MSK1 by
flow cytometry. Data from these analyses show that MDMs
treated with 25 µM cocaine showed significantly elevated
levels of phospho-p38 (Figure 8A) and phospho-MSK1 levels
(Figure 8B), relative to the untreated cells. In line with the
experiments with THP-1macs, the specificity of the activation
of p38 MAPK/MSK1 pathway in cocaine-treated MDMs was
investigated by using pharmacological inhibitors targeting p38
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FIGURE 7 | Cocaine enhances HIV-1 transcription in primary MDMs. Primary monocytes were isolated from blood of three different donors by Ficoll-based
separation method and differentiated into MDMs using M-CSF. MDMs were inoculated with pseudotyped HIV-1 virions and then cultured in the absence or presence
of 1–100 µM cocaine. Viral replication in MDMs was monitored 48–72 hpi by measuring the luciferase activity in the cell lysates. The results are expressed as
mean ± SE for three independent experiments for each donor. ∗p < 0.05 is for the comparison of cocaine treated cells vs. untreated cells.
FIGURE 8 | Induction of p38 MAPK/MSK1 signaling cascade in MDMs. MDMs were cultured in the absence or presence of 25 µM cocaine and analyzed by
flow cytometry to determine the levels of (A) phosphorylated p38 MAPK and (B) phosphorylated MSK1. To determine that cocaine specifically targets p38
MAPK/MSK1 pathway, MDMs were pretreated with 10 µM p38 MAPK inhibitor (SB-203580) or 10 µM MSK1 inhibitor (SB-747651A) prior to cocaine treatment.
Thereafter, cells were harvested and analyzed by flow cytometry to determine the (C) effects of p38 MAPK inhibitor on MSK1 phosphorylation, and (D) effects of
MSK1 inhibitor on MSK1 phosphorylation.
MAPK (SB-203580) or MSK1 (SB-747651A). Pretreatment with
10 µM concentration of the p38 MAPK inhibitor (Figure 8C)
or the MSK1 inhibitor (Figure 8D) abrogated the accumulation
of phospho-MSK1 in cocaine-treated MDMs. These findings
are in agreement with the data obtained from experiments
using THP-1macs (Figure 3) and thus strongly support our
hypothesis that cocaine activates p38 MAPK/MSK1 signaling in
macrophages.
DISCUSSION
There are approximately ∼36 million individuals currently
infected with HIV-1 worldwide1 (CDC, 2012). Substance abuse
serves as a powerful cofactor at every stage of the ongoing
global HIV-1 pandemic (Friedman et al., 2006; Sohler et al.,
1http://www.who.int/mediacentre/factsheets/fs360/en/index.html
Frontiers in Microbiology | www.frontiersin.org 9 June 2016 | Volume 7 | Article 823
fmicb-07-00823 June 8, 2016 Time: 15:16 # 10
Swepson et al. Cocaine Activates p38 MAPK/MSK1 in Macrophages
2007; Cofrancesco et al., 2008; Kipp et al., 2011). Clinical studies
suggest that substance abuse is associated with higher risk of
infection, increased viral load, accelerated disease progression
and worsening of AIDS-related mortality (Anthony et al., 1991;
Arnsten et al., 2001, 2002; Friedman et al., 2006; Sohler et al.,
2007; Cofrancesco et al., 2008; Kipp et al., 2011). Cocaine is a
commonly abused drug among HIV-1 infected patients (Pence
et al., 2008) and studies suggest an association between cocaine
use and worsening of HIV disease (Chaisson et al., 1989; Anthony
et al., 1991; Siddiqui et al., 1993; Larrat et al., 1996; Cofrancesco
et al., 2008; Cook et al., 2008; Baum et al., 2009; Cook, 2011). The
worsening effects of cocaine abuse is much pronounced on HIV-1
neuro-pathogenesis given that both cocaine and the virus target
the CNS (Buch et al., 2012).
HIV-1 infection in the brain results in a range of neurological
dysfunctions that are broadly termed as HAND (McArthur
et al., 2010). Neuronal apoptosis and neuro-inflammation in
the infected brain causes CNS dysfunction and injury (Kaul
et al., 2001). Even though the exact mechanism remains largely
unclear, since many of the drugs used in the ART regimen
do not penetrate the blood brain barrier (Ene et al., 2011),
persistent viral replication in the brain has been suggested to
play a key role for HAND pathogenesis (Ene et al., 2011).
Although neurons are refractory to HIV-1 infection (van de
Bovenkamp et al., 2002), microglia and resident macrophages
support HIV-1 infection in the brain (Koppensteiner et al., 2012).
It has been proposed that cocaine’s potentiating effects on HIV-1
replication in macrophages (Dhillon et al., 2007), play critical
roles in worsening of HIV-associated neurological complications
in drug abusing patients (Gonzalez-Scarano and Martin-Garcia,
2005). However, the underlying cellular signaling pathways that
contribute to HIV-1 infection and replication in the brain,
specifically in the macrophages, are not clearly delineated.
Cocaine is known to target several signaling pathways
including MAPK, PI3K/Akt, and MSK1, which can modulate
transcription of cellular genes (Yao et al., 2009; Yang et al.,
2010; Mannangatti et al., 2015). Importantly, MAPK and MSK1
signaling has also been shown to modulate HIV-1 replication,
by stimulating transcription from the viral LTR promoter
(Muthumani et al., 2004; Horie et al., 2007; Herbein et al., 2010).
For instance, HIV-1 transcription is induced by an activated p38
MAPK in macrophages (Kadoki et al., 2010), while inhibition
of p38 MAPK in PBMCs and chronically infected monocytic
cell lines diminished HIV-1 production (Shapiro et al., 1998).
Further in mammalian cells, p38 MAPK is phosphorylated in
response to a variety of environmental and cellular insults
including pathogens, heat shock, growth factors, osmotic shock,
ultraviolet irradiation, and cytokines (Cano and Mahadevan,
1995). Accordingly, p38 MAPK is a key modulator of HIV gene
expression in response to UV radiation (Taher et al., 1999). Since
cocaine is also known to modulate the p38 MAPK pathway (Yao
et al., 2009; Yang et al., 2010), we hypothesized that p38 MAPK is
involved in cocaine-induced activation of HIV-1 transcription in
macrophages. Our results show that cocaine treatment increased
HIV-1 transcription both in in THP1macs (Figure 1) and
primary MDMs (Figure 7). The concentrations of cocaine used
in this study ranged from 0.1 to 100 µM. These concentrations
were selected to mimic the varied range of plasma concentrations
of cocaine reported among drug users (Van Dyke et al., 1976;
Mittleman and Wetli, 1984; Peretti et al., 1990; Karch et al.,
1998; Blaho et al., 2000; Heard et al., 2008). The phosphorylation
status of p38 MAPK was also elevated in cocaine treatment
(Figures 2 and 8), thus indicating that cocaine augments p38
MAPK activity in macrophages. The activation of p38 MAPK
paralleled the increase in HIV-1 transcription. Accordingly,
the cocaine-induced enhancement of HIV-1 transcription was
abrogated when infected cells were pretreated, prior to cocaine
exposure, with p38 MAPK inhibitor (Figure 5). These results
strongly suggested that cocaine’s potentiating effects on HIV-1
transcription is dependent on activation of p38 MAPK in
macrophages.
Once p38 MAPK is activated by phosphorylation, it can
target and activate a range of downstream effector proteins
including several transcription factors and kinases that are
involved in the control of gene expression (Tiedje et al., 2014;
Yang et al., 2014). One such target of p38 MAPK is MSK1
(McCoy et al., 2005; Vermeulen et al., 2009), which can directly
activate transcription factors such as NF-κB- a well-known
stimulator of HIV-1 transcription (Nabel and Baltimore, 1987).
Furthermore, strong activation of MSK1 has also been reported
in response to cocaine, resulting in gene regulation critical
for long-term neuronal alterations leading to drug addiction
(Brami-Cherrier et al., 2005). Therefore, we investigated whether
cocaine-induced activation of p38 MAPK altered the status
of MSK1 activity in macrophages. MSK1 phosphorylation was
FIGURE 9 | Model proposing a role for cocaine-induced activation of
p38 MAPK/MSK1 signaling pathway in the induction of HIV-1
transcription in macrophages. We propose that cocaine enhances HIV-1
transcription in macrophages by activating the p38 MAPK/MSK1/H3 Ser10
pathway. Specifically, cocaine activates p38 MAPK in macrophages by
inducing phosphorylation of p38 MAPK. Consequently, the activated p38
MAPK induces phosphorylation of the downstream effector MSK1. The
activated MSK1 then phosphorylates H3 Ser10, which renders the host
chromatin accessible to transcription factors that then stimulate HIV-1
transcription. We hypothesize that cocaine-induced increase in HIV-1
transcription may increase the viral load in the CNS thus contributing to the
worsening of HIV-1 neuropathogenesis in drug-abusing HIV-1 infected
individuals.
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enhanced in cocaine-treated THP-1macs (Figures 2D–F) and
MDMs (Figure 8B), which juxtaposed well with the activation
of p38 MAPK. Pharmacological inhibition of p38 MAPK
prevented phosphorylation of MSK1 in cocaine-treated THP-
1macs (Figure 3) and MDMs (Figure 8). These data reveal
that MSK1 is a critical mediator of the p38 MAPK intracellular
signaling cascade in response to cocaine in macrophages.
The transcription of eukaryotic genes is regulated by
remodeling of chromatin structure (Fischle et al., 2003).
Histone H3 is a major nucleosomal protein involved in
the chromatin organization in the eukaryotic cells (Fischle
et al., 2003). To initiate transcription, the N-terminal tail
of histone H3 undergoes several modifications that induce
changes in the chromatin environment (Fischle et al., 2003).
The phosphorylation on serine 10 and acetylation on lysine
14 of histone H3 have been commonly associated with
genes that are being actively transcribed (Fischle et al.,
2003). MSK1, a key signaling molecule downstream of p38
MAPK (McCoy et al., 2005; Vermeulen et al., 2009), is
known to induce phosphorylation of H3 Ser10, thereby
resulting in transcriptional activation of cellular genes (Soloaga
et al., 2003). A recent study also suggested that H3 Ser10
phosphorylation drives HIV-1 transcription (Sahu et al., 2015).
Therefore, we investigated whether cocaine-mediated activation
of p38 MAPK/MSK1 signaling axis targeted H3 Ser10 in
macrophages. Cocaine caused a dose-dependent increase in
phosphorylation of H3 Ser10 (Figures 2G–I), with optimal
activation obtained at a concentration of 25 µM cocaine.
Fittingly, cells treated with 25 µM cocaine displayed the
greatest increase in p38 MAPK/MSK1 signaling and HIV-1
transcription. These data suggest that the positive effect of
cocaine on HIV-1 transcription stems most likely from the
H3 Ser10 phosphorylation executed by robustly activated p38
MAPK/MSK1 signaling pathway.
Collectively, our results demonstrate that cocaine enhances
HIV-1 transcription by a novel mechanism that involves the
p38 MAPK/MSK1/H3 Ser10 pathway (Figure 9). We show that
cocaine treatment causes activation of p38 MAPK, MSK1, and
H3 Ser10 in macrophages. These signaling events likely culminate
in the host chromatin, including the integrated provirus, gaining
access to transcription factors. The ensuing increase in HIV-
1 transcription can promote viral replication in macrophages,
accompanied by overproduction of viral neurotoxins in the
CNS. However, our results do not address the mechanism
by which cocaine activates p38 MAPK. Nevertheless, cocaine
is known to bind to the dopamine transporters (DAT; Ritz
et al., 1987; Chen et al., 2006), and activate signaling cascades
including p38 MAPK (Nair et al., 2005; Lepsch et al., 2009;
Yao et al., 2009; Yang et al., 2010). There is some evidence
that macrophages respond to dopamine signaling (Gaskill et al.,
2013, 2014). Therefore, it is plausible that cocaine activates
p38 MAPK in macrophages by utilizing the dopaminergic
signaling pathway. However, in the absence of data describing
expression of DAT on human macrophages, whether binding
of cocaine to DAT in these cells can activate p38 MAPK is yet
to be tested. Alternatively, based on the lipophilic properties,
cocaine can cross the plasma membrane in these cells and
induce p38 MAPK activation via mechanisms that are yet to
be clearly define. Currently, studies are underway to test these
hypotheses.
CONCLUSION
The results presented in this report provide new insights
into the complex interaction between drug abuse and HIV-
1 replication and describe a potential mechanism by which
cocaine exacerbates HIV-1 neuropathogenesis. Specifically, our
results highlight that cocaine enhances HIV-1 transcription in
macrophages by targeting p38 MAPK/MSK1/H3 Ser10 pathway.
Given that macrophages support HIV-1 replication in the CNS,
these results suggest that cocaine abuse potentially contributes
to the persistent HIV-1 replication and increased viral load in
the brain of infected patients. It is important to point out that
persistent HIV-1 replication albeit at low levels plays a critical role
in HAND pathogenesis that affects a large percentage of HIV-1
infected patients (Vivithanaporn et al., 2010). Therefore, our data
may have implications in reducing the burden of HAND and may
pave the way in identifying novel cellular pathways that could be
targeted for the treatment of HAND pathogenesis in drug abusing
patients.
AUTHOR CONTRIBUTIONS
CS, AR, and JP carried out the all the experiments. CD and JP
designed and directed the entire study. JP, MB, and CD analyzed
the data. JP and CD wrote the manuscript and all the authors
reviewed the manuscript.
ACKNOWLEDGMENTS
This work is partly supported by grants (DA024558, DA30896,
DA033892) from NIDA/NIH, the Vanderbilt CTSA grant UL1
RR024975-01 from NCRR/NIH, and the Meharry Translational
Research Center (MeTRC) CTSA grant (U54 RR026140 from
NCRR/NIH and U54 MD007593 from NIMHD/NIH to CD. CS
is supported by the Research Training Grant 2T32H2H007735-17
from NIH/NHLBI.
REFERENCES
Addai, A. B., Pandhare, J., Paromov, V., Mantri, C. K., Pratap, S., and Dash, C.
(2015). Cocaine modulates HIV-1 integration in primary CD4+ T cells:
implications in HIV-1 pathogenesis in drug-abusing patients. J. Leukoc. Biol.
97, 779–790. doi: 10.1189/jlb.4A0714-356R
Anthony, J. C., Vlahov, D., Nelson, K. E., Cohn, S., Astemborski, J., Solomon, L.,
et al. (1991). New evidence on intravenous cocaine use and the risk of
infection with human immunodeficiency virus type 1. Am. J. Epidemiol. 134,
1175–1189.
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch,
M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and
Frontiers in Microbiology | www.frontiersin.org 11 June 2016 | Volume 7 | Article 823
fmicb-07-00823 June 8, 2016 Time: 15:16 # 12
Swepson et al. Cocaine Activates p38 MAPK/MSK1 in Macrophages
viral suppression in HIV-infected drug users: comparison of self-report
and electronic monitoring. Clin. Infect. Dis. 33, 1417–1423. doi: 10.1086/
323201
Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H.,
Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy
adherence and viral suppression in HIV-infected drug users. J. Gen. Intern. Med.
17, 377–381. doi: 10.1007/s11606-002-0044-3
Bagasra, O., and Pomerantz, R. J. (1993). Human immunodeficiency virus type 1
replication in peripheral blood mononuclear cells in the presence of cocaine.
J. Infect. Dis. 168, 1157–1164. doi: 10.1093/infdis/168.5.1157
Baum, M. K., Rafie, C., Lai, S., Sales, S., Page, B., and Campa, A. (2009).
Crack-cocaine use accelerates HIV disease progression in a cohort of
HIV-positive drug users. J. Acquir. Immune Defic. Syndr. 50, 93–99. doi:
10.1097/QAI.0b013e3181900129
Blaho, K., Logan, B., Winbery, S., Park, L., and Schwilke, E. (2000). Blood
cocaine and metabolite concentrations, clinical findings, and outcome of
patients presenting to an ED. Am. J. Emerg. Med. 18, 593–598. doi:
10.1053/ajem.2000.9282
Brami-Cherrier, K., Valjent, E., Hervé, D., Darragh, J., Corvol, J. C., Pages, C., et al.
(2005). Parsing molecular and behavioral effects of cocaine in mitogen- and
stress-activated protein kinase-1-deficient mice. J. Neurosci. 25, 11444–11454.
doi: 10.1523/JNEUROSCI.1711-05.2005
Buch, S., Yao, H., Guo, M., Mori, T., Mathias-Costa, B., Singh, V., et al. (2012).
Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms. Curr.
HIV Res. 10, 425–428. doi: 10.2174/157016212802138823
Cano, E., and Mahadevan, L. C. (1995). Parallel signal processing among
mammalian MAPKs. Trends Biochem. Sci. 20, 117–122. doi: 10.1016/S0968-
0004(00)88978-1
CDC (2012). HIV Surveillance Report. Available at: http://www.cdc.gov/hiv/
topics/surveillance/resources/22
Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., and Moss,
A. R. (1989). Cocaine use and HIV infection in intravenous drug users
in San Francisco. JAMA 261, 561–565. doi: 10.1001/jama.1989.034200400
99027
Chen, R., Michael, R., Tilley, H. W., Fuwen, Z., Fu-Ming, Z., San, C.,
et al. (2006). Abolished cocaine reward in mice with a cocaine-insensitive
dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 103, 9333–9338. doi:
10.1073/pnas.0600905103
Cofrancesco, J. Jr., Rebecca, S., Tien, P. C., Gibert, C. L., Southwell, H., Sidney, S.,
et al. (2008). Illicit drug use and HIV treatment outcomes in a US cohort. AIDS
22, 357–365. doi: 10.1097/QAD.0b013e3282f3cc21
Cook, J. A. (2011). Associations between use of crack cocaine and HIV-1
disease progression: research findings and implications for mother-to-infant
transmission. Life Sci. 88, 931–939. doi: 10.1016/j.lfs.2011.01.003
Cook, J. A., Burke-Miller, J. K., Cohen, M. H., Cook, R. L., Vlahov, D., Wilson,
T. E., et al. (2008). Crack cocaine, disease progression, and mortality in
a multicenter cohort of HIV-1 positive women. AIDS 22, 1355–1363. doi:
10.1097/QAD.0b013e32830507f2
Davies, S. P., Reddy, H., Caivano, M., and Cohen, P. (2000). Specificity and
mechanism of action of some commonly used protein kinase inhibitors.
Biochem. J. 351(Pt 1), 95–105. doi: 10.1042/bj3510095
Dhillon, N. K., Williams, R., Peng, F., Tsai, Y. J., Dhillon, S., Nicolay, B.,
et al. (2007). Cocaine-mediated enhancement of virus replication
in macrophages: implications for human immunodeficiency virus-
associated dementia. J. Neurovirol. 13, 483–495. doi: 10.1080/13550280701
528684
Dreskin, S. C., Thomas, G. W., Dale, S. N., and Heasley, L. E. (2001).
Isoforms of Jun kinase are differentially expressed and activated in human
monocyte/macrophage (THP-1) cells. J. Immunol. 166, 5646–5653. doi:
10.4049/jimmunol.166.9.5646
Ene, L., Duiculescu, D., and Rutta, S. M. (2011). How much do antiretroviral drugs
penetrate into the central nervous system? J. Med. Life 4, 432–439.
Ferris, M. J., Mactutus, C. F., and Booze, R. M. (2008). Neurotoxic profiles of HIV,
psychostimulant drugs of abuse, and their concerted effect on the brain: current
status of dopamine system vulnerability in NeuroAIDS. Neurosci. Biobehav.
Rev. 32, 883–909. doi: 10.1016/j.neubiorev.2008.01.004
Fischle, W., Wang, Y., and Allis, C. D. (2003). Histone and chromatin cross-talk.
Curr. Opin. Cell Biol. 15, 172–183. doi: 10.1016/S0955-0674(03)00013-9
Friedman, H., Pross, S., and Klein, T. W. (2006). Addictive drugs and their
relationship with infectious diseases. FEMS Immunol. Med. Microbiol. 47,
330–342. doi: 10.1111/j.1574-695X.2006.00097.x
Gaskill, P. J., Calderon, T. M., Coley, J. S., and Berman, J. W. (2013). Drug
induced increases in CNS dopamine alter monocyte, macrophage and T cell
functions: implications for HAND. J. Neuroimmune Pharmacol. 8, 621–642.
doi: 10.1007/s11481-013-9443-y
Gaskill, P. J., Yano, H. H., Kalpana, G. V., Javitch, J. A., and Berman,
J. W. (2014). Dopamine receptor activation increases HIV entry into
primary human macrophages. PLoS ONE 9:e108232. doi: 10.1371/journal.pone.
0108232
Gomez-Marin, J. E., Valere, A., Bonhomme, A., el’Btaouri, H., Antonicelli, F.,
Burlet, H., et al. (1998). Interferon-gamma signal transduction during parasite
infection: modulation of MAP kinases in the infection of human monocyte
cells (THP1) by Toxoplasma gondii. Parasite Immunol. 20, 631–635. doi:
10.1046/j.1365-3024.1998.00194.x
Gonzalez-Scarano, F., and Martin-Garcia, J. (2005). The neuropathogenesis of
AIDS. Nat. Rev. Immunol. 5, 69–81. doi: 10.1038/nri1527
Goodwin, G. M., Pretsell, D. O., Chiswick, A., Egan, V. and Brettle, R. P. (1996).
The Edinburgh cohort of HIV-positive injecting drug users at 10 years after
infection: a case-control study of the evolution of dementia. AIDS 10, 431–440.
doi: 10.1097/00002030-199604000-00012
Grivel, J. C., Shattock, R. J., and Margolis, L. B. (2011). Selective transmission of
R5 HIV-1 variants: where is the gatekeeper? J. Transl. Med. 9(Suppl. 1), S6. doi:
10.1186/1479-5876-9-S1-S6
Heard, K., Palmer, R., and Zahniser, N. R. (2008). Mechanisms of acute cocaine
toxicity. Open Pharmacol. J. 2, 70–78. doi: 10.2174/1874143600802010070
Herbein, G., Gras, G., Khan, K. A., and Abbas, W. (2010). Macrophage signaling in
HIV-1 infection. Retrovirology 7:34. doi: 10.1186/1742-4690-7-34
Horie, R., Ishida, T., Maruyama-Nagai, M., Ito, K., Watanabe, M., Yoneyama, A.,
et al. (2007). TRAF activation of C/EBPbeta (NF-IL6) via p38 MAPK induces
HIV-1 gene expression in monocytes/macrophages. Microbes Infect. 9, 721–728.
doi: 10.1016/j.micinf.2007.02.017
Huang, J., Wang, F., Argyris, E., Chen, K., Liang, Z., Tian, H., et al.
(2007). Cellular microRNAs contribute to HIV-1 latency in resting
primary CD4+ T lymphocytes. Nat. Med. 13, 1241–1247. doi: 10.1038/
nm1639
Joska, J. A., Gouse, H., Paul, R. H., Stein, D. J., and Flisher, A. J. (2010).
Does highly active antiretroviral therapy improve neurocognitive function?
A systematic review. J. Neurovirol. 16, 101–114. doi: 10.3109/1355028100
3682513
Kadoki, M., Choi, B., and Iwakura, Y. (2010). The mechanism of LPS-induced HIV
type I activation in transgenic mouse macrophages. Int. Immunol. 22, 469–478.
doi: 10.1093/intimm/dxq032
Karch, S. B., Stephens, B., and Ho, C. H. (1998). Relating cocaine blood
concentrations to toxicity–an autopsy study of 99 cases. J. Forensic Sci. 43,
41–45. doi: 10.1520/JFS16087J
Kaul, M., Garden, G. A., and Lipton, S. A. (2001). Pathways to neuronal
injury and apoptosis in HIV-associated dementia. Nature 410, 988–994. doi:
10.1038/35073667
Keum, Y. S., Kim, H. G., Bode, A. M., Surh, Y. J., and Dong, Z. (2013). UVB-
induced COX-2 expression requires histone H3 phosphorylation at Ser10 and
Ser28. Oncogene 32, 444–452. doi: 10.1038/onc.2012.71
Kim, S. G., Jung, J. B., Dixit, D., Rovner, R. Jr., Zack, J. A., Baldwin, G. C., et al.
(2013). Cocaine exposure enhances permissiveness of quiescent T cells to HIV
infection. J. Leukoc. Biol. 94, 835–843. doi: 10.1189/jlb.1112566
Kipp, A. M., Desruisseau, A. J., and Qian, H. Z. (2011). Non-injection drug use
and HIV disease progression in the era of combination antiretroviral therapy.
J. Subst. Abuse Treat. 40, 386–396. doi: 10.1016/j.jsat.2011.01.001
Koppensteiner, H., Brack-Werner, R., and Schindler, M. (2012). Macrophages
and their relevance in Human Immunodeficiency Virus Type I infection.
Retrovirology 9:82. doi: 10.1186/1742-4690-9-82
Larrat, E. P., and Zierler, S. (1993). Entangled epidemics: cocaine
use and HIV disease. J. Psychoactive Drugs 25, 207–221. doi:
10.1080/02791072.1993.10472272
Larrat, E. P., Zierler, S., and Mayer, K. (1996). Cocaine use and HIV disease
progression among heterosexuals. Pharmacoepidemiol. Drug Saf. 5, 229–236.
doi: 10.1002/(SICI)1099-1557(199607)5:4<229::AID-PDS213>3.0.CO;2-6
Frontiers in Microbiology | www.frontiersin.org 12 June 2016 | Volume 7 | Article 823
fmicb-07-00823 June 8, 2016 Time: 15:16 # 13
Swepson et al. Cocaine Activates p38 MAPK/MSK1 in Macrophages
Lepsch, L. B., Munhoz, C. D., Kawamoto, E. M., Yshii, L. M., Lima, L. S.,
and Curi-Boaventura, M. F. (2009). Cocaine induces cell death and activates
the transcription nuclear factor kappa-B in PC12 cells. Mol. Brain 2:3. doi:
10.1186/1756-6606-2-3
Mannangatti, P., NarasimhaNaidu, K., Damaj, M. I., Ramamoorthy, S., and
Jayanthi, L. D. (2015). A Role for p38 mitogen-activated protein kinase-
mediated threonine 30-dependent norepinephrine transporter regulation in
cocaine sensitization and conditioned place preference. J. Biol. Chem. 290,
10814–10827. doi: 10.1074/jbc.M114.612192
Mantri, C. K., Pandhare Dash, J., Mantri, J. V., and Dash, C. C. (2012). Cocaine
enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b.
PLoS ONE 7: e51387. doi: 10.1371/journal.pone.0051387
McArthur, J. C., Steiner, J., Sacktor, N., and Nath, A. (2010). Human
immunodeficiency virus-associated neurocognitive disorders: mind the gap.
Ann. Neurol. 67, 699–714.
McCoy, C. E., Campbell, D. G., Deak, M., Bloomberg, G. B., and Arthur, J. S. (2005).
MSK1 activity is controlled by multiple phosphorylation sites. Biochem. J. 387,
507–517. doi: 10.1042/BJ20041501
McCoy, C. E., Macdonald, A., Morrice, N. A., Campbell, D. G., Deak, M.,
Toth, R., et al. (2007). Identification of novel phosphorylation sites in MSK1
by precursor ion scanning MS. Biochem. J. 402, 491–501. doi: 10.1042/BJ200
61183
Mittleman, R. E., and Wetli, C. V. (1984). Death caused by recreational cocaine use.
An update. JAMA 252, 1889–1893. doi: 10.1001/jama.1984.03350140035021
Muthumani, K., Wadsworth, S. A., Dayes, N. S., Hwang, D. S., Choo, A. Y.,
Abeysinghe, H. R., et al. (2004). Suppression of HIV-1 viral replication and
cellular pathogenesis by a novel p38/JNK kinase inhibitor. AIDS 18, 739–748.
doi: 10.1097/00002030-200403260-00004
Nabel, G., and Baltimore, D. (1987). An inducible transcription factor activates
expression of human immunodeficiency virus in T cells. Nature 326, 711–713.
doi: 10.1038/326711a0
Nair, M. P., Chadha, K. C., Hewitt, R. G., Mahajan, S., Sweet, A., and
Schwartz, S. A. (2000). Cocaine differentially modulates chemokine production
by mononuclear cells from normal donors and human immunodeficiency
virus type 1-infected patients. Clin. Diagn. Lab. Immunol. 7, 96–100. doi:
10.1128/cdli.7.1.96-100.2000
Nair, M. P., Mahajan, S., Chadha, K. C., Nair, N. M., Hewitt, R. G., Pillai, S. K.,
et al. (2001). Effect of cocaine on chemokine and CCR-5 gene expression by
mononuclear cells from normal donors and HIV-1 infected patients. Adv. Exp.
Med. Biol. 493, 235–240. doi: 10.1007/0-306-47611-8_28
Nair, M. P., Mahajan, S. D., Schwartz, S. A., Reynolds, J., Whitney, R.,
Bernstein, Z., et al. (2005). Cocaine modulates dendritic cell-specific
C type intercellular adhesion molecule-3-grabbing nonintegrin expression
by dendritic cells in HIV-1 patients. J. Immunol. 174, 6617–6626. doi:
10.4049/jimmunol.174.11.6617
Napuri, J., Pilakka-Kanthikeel, S., Raymond, A., Agudelo, M., Yndart-Arias, A.,
Saxena, S. K., et al. (2013). Cocaine enhances HIV-1 infectivity in monocyte
derived dendritic cells by suppressing microRNA-155. PLoS ONE 8:e83682. doi:
10.1371/journal.pone.0083682
Naqvi, S., Macdonald, A., McCoy, C. E., Darragh, J., Reith, A. D., and Arthur,
J. S. (2012). Characterization of the cellular action of the MSK inhibitor
SB-747651A. Biochem. J. 441, 347–357. doi: 10.1042/BJ20110970
Nath, A. (2002). Human immunodeficiency virus (HIV) proteins in
neuropathogenesis of HIV dementia. J. Infect. Dis. 186(Suppl. 2), S193–S198.
doi: 10.1086/344528
Nath, A., Maragos, W. F., Avison, M. J., Schmitt, F. A., and Berger, J. R.
(2001). Acceleration of HIV dementia with methamphetamine and cocaine.
J. Neurovirol. 7, 66–71. doi: 10.1080/135502801300069737
Nong, Y., Kandil, O., Tobin, E. H., Rose, R. M., and Remold, H. G. (1991). The HIV
core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and
cytochrome b heavy chain mRNA levels in the human monocyte-like cell line
THP1. Cell Immunol. 132, 10–16. doi: 10.1016/0008-8749(91)90002-S
Norman, L. R., Basso, M., Kumar, A., and Malow, R. (2009). Neuropsychological
consequences of HIV and substance abuse: a literature review and implications
for treatment and future research. Curr. Drug Abuse Rev. 2, 143–156. doi:
10.2174/1874473710902020143
Pakesch, G., Loimer, N., Grünberger, J., Pfersmann, D., Linzmayer, L., and
Mayerhofer, S. (1992). Neuropsychological findings and psychiatric symptoms
in HIV-1 infected and noninfected drug users. Psychiatry Res. 41, 163–177. doi:
10.1016/0165-1781(92)90108-F
Patel, S. M., Thames, A. D., Arbid, N., Panos, S. E., Castellon, S., and Hinkin, C. H.
(2013). The aggregate effects of multiple comorbid risk factors on cognition
among HIV-infected individuals. J. Clin. Exp. Neuropsychol. 35, 421–434. doi:
10.1080/13803395.2013.783000
Pence, B. W., Thielman, N. M., Whetten, K., Ostermann, J., Kumar, V., and
Mugavero, M. J. (2008). Coping strategies and patterns of alcohol and drug use
among HIV-infected patients in the United States Southeast. AIDS Patient Care
STDS 22, 869–877. doi: 10.1089/apc.2008.0022
Peretti, F. J., Isenschmid, D. S., Levine, B., Caplan, Y. H., and Smialek,
J. E. (1990). Cocaine fatality: an unexplained blood concentration in a
fatal overdose. Forensic Sci. Int. 48, 135–138. doi: 10.1016/0379-0738(90)
90105-8
Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Molitor, T. W., and Balfour, H. H.
Jr. (1991). Cocaine potentiates HIV-1 replication in human peripheral blood
mononuclear cell cocultures. Involvement of transforming growth factor-beta.
J. Immunol. 146, 81–84.
Peterson, P. K., Gekker, G., Chao, C. C., Schut, R., Verhoef, J., Edelman, C. K., et al.
(1992). Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated
peripheral blood mononuclear cell cocultures. J. Immunol. 149, 676–680.
Rao, V. R., Ruiz, A. P., and Prasad, V. R. (2014). Viral and cellular factors
underlying neuropathogenesis in HIV associated neurocognitive disorders
(HAND). AIDS Res. Ther. 11:13. doi: 10.1186/1742-6405-11-13
Reynolds, J. L., Mahajan, S. D., Aalinkeel, R., Nair, B., Sykes, D. E., Agosto-
Mujica, A., et al. (2009). Modulation of the proteome of peripheral blood
mononuclear cells from HIV-1-infected patients by drugs of abuse. J. Clin.
Immunol. 29, 646–656. doi: 10.1007/s10875-009-9309-5
Reynolds, J. L., Mahajan, S. D., Bindukumar, B., Sykes, D., Schwartz, S. A., and Nair,
M. P. (2006). Proteomic analysis of the effects of cocaine on the enhancement
of HIV-1 replication in normal human astrocytes (NHA). Brain Res. 1123,
226–236. doi: 10.1016/j.brainres.2006.09.034
Ritz, M. C., Lamb, R. J., Goldberg, S. R., and Kuhar, M. J. (1987). Cocaine receptors
on dopamine transporters are related to self-administration of cocaine. Science
237, 1219–1223. doi: 10.1126/science.2820058
Roth, M. D., Whittaker, K. M., Choi, R., Tashkin, D. P., and Baldwin, G. C. (2005).
Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors,
and the HPA axis in the huPBL-SCID model. J. Leukoc. Biol. 78, 1198–1203. doi:
10.1189/jlb.0405219
Sahu, G., Farley, K., El-Hage, N., Aiamkitsumrit, B., Fassnacht, R., Kashanchi, F.,
et al. (2015). Cocaine promotes both initiation and elongation phase of
HIV-1 transcription by activating NF-kappaB and MSK1 and inducing
selective epigenetic modifications at HIV-1 LTR. Virology 483, 185–202. doi:
10.1016/j.virol.2015.03.036
Sanmarti, M., Ibanez, L., Huertas, S., Badenes, D., Dalmau, D., Slevin, M., et al.
(2014). HIV-associated neurocognitive disorders. J. Mol. Psychiatry 2: 2. doi:
10.1186/2049-9256-2-2
Shapiro, L., Heidenreich, K. A., Meintzer, M. K., and Dinarello, C. A. (1998). Role
of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc.
Natl. Acad. Sci. U.S.A. 95, 7422–7426. doi: 10.1073/pnas.95.13.7422
Siddiqui, N. S., Brown, L. S. Jr., and Makuch, R. W. (1993). Short-term declines in
CD4 levels associated with cocaine use in HIV-1 seropositive, minority injecting
drug users. J. Natl. Med. Assoc. 85, 293–296.
Sohler, N. L., Wong, M. D., Cunningham, W. E., Cabral, H., Drainoni, M. L.,
and Cunningham, C. O. (2007). Type and pattern of illicit drug use and
access to health care services for HIV-infected people. AIDS Patient Care STDS
21(Suppl. 1), S68–S76. doi: 10.1089/apc.2007.9985
Soloaga, A., Thomson, S., Wiggin, G. R., Rampersaud, N., Dyson, M. H., Hazzalin,
C. A., et al. (2003). MSK2 and MSK1 mediate the mitogen- and stress-induced
phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788–2797. doi:
10.1093/emboj/cdg273
Taher, M. M., Baumgardner, T., Dent, P., and Valerie, K. (1999). Genetic evidence
that stress-activated p38 MAP kinase is necessary but not sufficient for
UV activation of HIV gene expression. Biochemistry 38, 13055–13062. doi:
10.1021/bi9902900
Tiedje, C., Holtmann, H., and Gaestel, M. (2014). The role of mammalian MAPK
signaling in regulation of cytokine mRNA stability and translation. J. Interferon
Cytokine Res. 34, 220–232. doi: 10.1089/jir.2013.0146
Frontiers in Microbiology | www.frontiersin.org 13 June 2016 | Volume 7 | Article 823
fmicb-07-00823 June 8, 2016 Time: 15:16 # 14
Swepson et al. Cocaine Activates p38 MAPK/MSK1 in Macrophages
van de Bovenkamp, M., Nottet, H. S., and Pereira, C. F. (2002). Interactions
of human immunodeficiency virus-1 proteins with neurons: possible
role in the development of human immunodeficiency virus-1-associated
dementia. Eur. J. Clin. Invest. 32, 619–627. doi: 10.1046/j.1365-2362.2002.
01029.x
Van Dyke, C., Barash, P. G., Jatlow, P., and Byck, R. (1976). Cocaine: plasma
concentrations after intranasal application in man. Science 191, 859–861. doi:
10.1126/science.56036
Vermeulen, L., Vanden Berghe, W., Beck, I. M., De Bosscher, K., and
Haegeman, G. (2009). The versatile role of MSKs in transcriptional
regulation. Trends Biochem. Sci. 34, 311–318. doi: 10.1016/j.tibs.2009.
02.007
Vivithanaporn, P., Heo, G., Gamble, J., Krentz, H. B., Hoke, A., Gill,
M. J., et al. (2010). Neurologic disease burden in treated HIV/AIDS
predicts survival: a population-based study. Neurology 75, 1150–1158. doi:
10.1212/WNL.0b013e3181f4d5bb
Vuletic, S., Dong, W., Wolfbauer, G., Tang, C., and Albers, J. J. (2011).
PLTP regulates STAT3 and NFkB in differentiated THP1 cells and human
monocyte-derived macrophages. Biochim. Biophys. Acta 1813, 1917–1924. doi:
10.1016/j.bbamcr.2011.06.013
Woods, S. P., Moore, D. J., Weber, E., and Grant, I. (2009). Cognitive
neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol.
Rev. 19, 152–168. doi: 10.1007/s11065-009-9102-5
Yang, Y., Kim, S. C., Yu, T., Yi, Y. S., Rhee, M. H., Sung, G. H., et al. (2014).
Functional roles of p38 mitogen-activated protein kinase in macrophage-
mediated inflammatory responses. Mediators Inflamm. 2014: 352371. doi:
10.1155/2014/352371
Yang, Y., Yao, H., Lu, Y., Wang, C., and Buch, S. (2010). Cocaine potentiates
astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein
gp120. PLoS ONE 5: e13427. doi: 10.1371/journal.pone.0013427
Yao, H., Allen, J. E., Zhu, X., Callenm, S., and Buch, S. (2009). Cocaine
and human immunodeficiency virus type 1 gp120 mediate neurotoxicity
through overlapping signaling pathways. J Neurovirol 15, 164–175. doi:
10.1080/13550280902755375
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Swepson, Ranjan, Balasubramaniam, Pandhare and Dash. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Microbiology | www.frontiersin.org 14 June 2016 | Volume 7 | Article 823
